Skip to main content
. 2015 Mar 24;112(8):1398–1404. doi: 10.1038/bjc.2015.104

Table 3. Combined occurrence of GNAS and KRAS mutations in each duodenal lesion.

  Total number GNAS(+)/KRAS(+) GNAS(+)/KRAS(−) GNAS(−)/KRAS(+) GNAS(−)/KRAS(−)
Gastric foveolar metaplasia 66 8 (12%) 19 (29%)* 9 (14%) 30 (45%)
Gastric heterotopia 81 2 (2%) 21 (26%) 0 58 (72%)
Adenocarcinoma 30 1 (3%) 4 (13%) 10 (33%) 15 (50%)
*

One lesion had concurrent GNAS and BRAF mutations.